Login / Signup

Use of octreotide for the treatment of protein-losing enteropathy in dogs: Retrospective study of 18 cases.

Sara A JablonskiAllison S W MazepaMary Katherine Tolbert
Published in: Journal of veterinary internal medicine (2023)
Octreotide was most commonly prescribed to dogs with PLE and suspected or confirmed IL that had failed to respond to standard therapies. Though a benefit to PLE dogs cannot be confirmed, octreotide was well tolerated by the majority of dogs at the doses prescribed in this study.
Keyphrases
  • neuroendocrine tumors
  • pulmonary embolism
  • small molecule